CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke

Trial StartPositive
AI Analysis

Summary

WallabyPhenox announced the first patient enrollment in the PROMISE study evaluating a treatment for medium vessel occlusion stroke.

Clinical Trial Data

Patients

1

Outcome Details

First patient enrolled in PROMISE study

Importance:3/10
Sentiment:
0.30
clinical trialstroketrial initiationmedium vessel occlusion
Related Companies
$TRAX

Read the original article

Published by GlobeNewswire Clinical Studies on August 13, 2026 12:00 PM

Read Original